A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00287521 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: AL-37807 Ophthalmic Suspension, 1.0%
DRUG: Latanoprost, 0.005% (Xalatan)
OTHER: AL-37807 Vehicle
DRUG: Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%

Sponsor

Alcon Research